Studying the gene defects underlying the recurrent inflammatory episodes has revealed key immune pathways underlying persistent inflammation such as excessive IL‐1 signaling, constitutive NF‐κB activation, and chronic type I IFN signaling.142 VEO‐IBD has been described as an accompanying phenotype in a number of systemic autoinflammatory diseases. This evidence concerns the gene IL1B and inflammatory bowel disease.